search
Back to results

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations (RESOLUTE)

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Benralizumab
Placebo
Sponsored by
AstraZeneca
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring Chronic Obstructive Pulmonary Disease, COPD, benralizumab, Fasenra, ICS, inhaled corticosteroids, exacerbations, Lung Disease, LABA/LAMA

Eligibility Criteria

40 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Provision of informed consent
  2. Age 40 to 85 years
  3. Male and/or female.
  4. Current or former smoker with a tobacco history of ≥10 pack-years.
  5. History of moderate to very severe COPD with a post-bronchodilator FEV1/FVC<0.70 and FEV1 ≤65% of predicted normal value.
  6. Documented history of 2 or more COPD exacerbations that required treatment with systemic corticosteroids and/or hospitalization within 52 weeks prior to enrollment.

    1. Exacerbations treated with antibiotics alone are excluded unless accompanied by treatment with systemic corticosteroids and/or hospitalization.
    2. Hospitalization is defined as an inpatient admission ≥24 hours
    3. Previous exacerbations should be confirmed to have occurred while on stable triple therapy for COPD.
    4. At least one qualifying COPD exacerbation should occur while on stable uninterrupted triple therapy prior to enrolment.
  7. Documented use of triple (ICS/LABA/LAMA) background therapy for COPD for ≥3 months immediately prior to enrollment.

    1. Treatment with at least double inhaled therapy containing ICS (e.g. ICS/LABA or ICS/LAMA) for the remaining of 52 weeks prior to enrolment. Use of LABA/LAMA is allowed if ICS cannot be tolerated.
    2. ICS in a dose approved for COPD or equivalent to ≥250 mcg of fluticasone propionate daily.
    3. Total cumulative duration of not being on double or triple background therapy must not exceed 2 months.
    4. Stable therapy/doses for the last 3 months prior to randomization.
  8. Blood eosinophil count ≥300/μL at screening and documented historical eosinophil count of ≥150/μL within 52 weeks of enrollment (or repeated testing during run-in).
  9. CAT total score ≥15 at Visit 1.
  10. Negative pregnancy test for females of childbearing potential (WOCBP) at Visit 1.
  11. Women of childbearing potential (WOCBP) must agree to use a highly effective method of birth control from enrollment throughout the study and within 12 weeks after last dose of IP.

Women not of childbearing potential are defined as women who are either permanently sterilized or postmenopausal (confirmed by FSH test for women <50 years).

Exclusion Criteria:

  1. Clinically important pulmonary disease other than COPD
  2. Current diagnosis of asthma, prior history of asthma or asthma-COPD overlap according to GINA/GOLD. Childhood history of asthma is allowed and defined as asthma diagnosed and resolved before the age of 18.
  3. Radiological findings of a respiratory disease other than COPD contributing to respiratory symptoms. Solitary pulmonary nodules without appropriate follow up or findings of acute infection.
  4. Another pulmonary or systemic disease associated with elevated peripheral eosinophil counts.
  5. Any unstable disorder that could affect patient safety, study findings or the patient's ability to complete the study.
  6. Any clinically significant abnormal findings in physical examination, vital signs, ECG, laboratory tests could affect patient safety, study findings or the patient's ability to complete the study.
  7. Cor pulmonale and/or right ventricular failure.
  8. Long-term treatment with oxygen >4.0 L/min and/or oxyhemoglobin saturation <89% while breathing supplemental oxygen.
  9. Use of any non-invasive positive pressure ventilation device (NIPPV). Note: use of CPAP for Sleep Apnea Syndrome is allowed.
  10. Known immunodeficiency disorder, including positive HIV-1/2 testing.
  11. Active liver disease. Chronic stable hepatitis B and C (including positive HBsAg or hepatitis C antibody testing), or other stable chronic liver disease are acceptable.
  12. ALT or AST ≥3 times the upper limit of normal, confirmed by repeated testing during the run-in period.
  13. Helminth parasitic infection within 24 weeks prior to enrollment, not treated or failed to respond to standard of care therapy.
  14. Alcohol or drug abuse within the past year, which may compromise the study data.
  15. Malignancy, current or within the past 5 years, except for adequately treated non invasive basal cell and squamous cell carcinoma of the skin and cervical carcinoma-in-situ treated with apparent success more than 1 year prior to Visit 1. Suspected malignancy or undefined neoplasms.
  16. Evidence of active tuberculosis, as judged by investigator. Patients with a recent (within 2 years) first-time or newly positive PPD or Quantiferon test need to complete an appropriate course of treatment before enrollment. Evaluation will be according to the local standard of care.
  17. Participation, or planned participation, in intensive COPD rehabilitation program (maintenance phase of a rehabilitation is allowed).
  18. History of surgical or endoscopic lung volume reduction within the 6 months prior to enrollment. History of partial or total lung resection (single lobe or segmentectomy is acceptable).
  19. Scheduled major surgical procedure during the study. Minor elective procedures are allowed.
  20. History of anaphylaxis to any biologic therapy or vaccine.
  21. Receipt of blood products or immunoglobulins within 30 days prior to randomization.
  22. Receipt of marketed or investigational biologic product within 4 months or 5 half-lives prior to randomization, whichever is longer. Exception: Patients on stable therapy for 3 months before randomization who intend to stay on treatment throughout the study with marketed biologic products that are not likely to interfere with the safety assessment and/or efficacy of benralizumab, for example, for the treatment of osteoporosis, migraine, pain, diabetes, obesity, ocular, cardiovascular, or metabolic diseases, can participate in the study.
  23. Receipt of live attenuated vaccines 30 days prior to randomization.
  24. Chronic use of immunosuppressive medication or expected need for chronic use during the study.
  25. Chronic use of antibiotics if duration of treatment is <9 months prior to randomization. Chronic macrolide or other antibiotic therapy is allowed provided the patient has been on stable dose/regimen for ≥9 months prior to randomization and has had ≥2 COPD exacerbations while on stable therapy.
  26. Receipt of any investigational non-biologic product within 30 days or 5 half-lives prior to enrollment.
  27. Receipt of benralizumab within 12 months prior to enrollment.
  28. Known history of allergy or reaction to any component of the IP formulation.

Sites / Locations

  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research Site
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research SiteRecruiting
  • Research Site
  • Research Site
  • Research Site

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Benralizumab

Placebo

Arm Description

Administrated subcutaneously (SC) every 4 weeks for the first 3 doses, then every 8 weeks

Administrated subcutaneously every 4 weeks for the first 3 doses, then every 8 weeks

Outcomes

Primary Outcome Measures

Annualized rate of moderate or severe COPD exacerbations
Moderate or severe COPD exacerbation is defined by symptomatic worsening of COPD requiring: Use of systemic corticosteroids for at least 3 days; and/or Use of antibiotics; and/or An inpatient hospitalization or death due to COPD

Secondary Outcome Measures

Annualized rate of severe COPD exacerbations
A severe COPD exacerbation is defined by symptomatic worsening of COPD requiring an inpatient hospitalization or results in death due to COPD
Annualized rate of COPD exacerbations that are associated with an emergency room/emergency department visit or a hospitalization
Time to first COPD exacerbation
Change from baseline in SGRQ total and domain scores
St. George's Respiratory Questionnaire (SGRQ)
Change from baseline in E-RS:COPD total and domain scores
Evaluating Respiratory Symptoms in COPD (E-RS:COPD)
Change from baseline in pre-dose/pre-bronchodilator FEV1
FEV1 is the Forced expiratory volume in one second at study site
All cause and respiratory-related mortality rate
Annual rate of hospitalizations due to COPD
Serum benralizumab concentration as a measure of pharmacokinetics
Anti-drug antibodies (ADA) as a measure of immunogenicity
Change from baseline in CAT total score
Chronic Obstructive Pulmonary Disease assessment tool (CAT)
Length of hospital stay
ICU (Intensive Care Unit) days
Annual rate of hospitalizations and emergency department visits combined
Annual rate of unscheduled outpatient visits including unscheduled visits to study sites
Annual rate of unscheduled healthcare encounters

Full Information

First Posted
July 16, 2019
Last Updated
October 17, 2023
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT04053634
Brief Title
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Acronym
RESOLUTE
Official Title
A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils (RESOLUTE)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 26, 2019 (Actual)
Primary Completion Date
June 27, 2025 (Anticipated)
Study Completion Date
June 27, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AstraZeneca

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (≥300/μL). Eligible patients must have a history of ≥2 moderate and/or severe COPD exacerbations in the previous year despite receiving triple (ICS/LABA/LAMA) background therapy for at least 3 months and ICS-based dual inhaled treatment for the remainder of the year. Eligible patients must also have an elevated blood eosinophil count. The treatment period will be of variable duration and will continue until the last patient has the opportunity to complete a minimum of 56 weeks, at which point all patients will complete the study. The primary endpoint will be analyzed at Week 56.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
Chronic Obstructive Pulmonary Disease, COPD, benralizumab, Fasenra, ICS, inhaled corticosteroids, exacerbations, Lung Disease, LABA/LAMA

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
642 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Benralizumab
Arm Type
Experimental
Arm Description
Administrated subcutaneously (SC) every 4 weeks for the first 3 doses, then every 8 weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Administrated subcutaneously every 4 weeks for the first 3 doses, then every 8 weeks
Intervention Type
Biological
Intervention Name(s)
Benralizumab
Intervention Description
Benralizumab solution for injection in accessorized prefilled syringe (APFS) will be administered subcutaneously (SC) every 4 weeks for the first 3 doses - Weeks 0, 4 and 8, and then every 8 weeks until the end of treatment.
Intervention Type
Biological
Intervention Name(s)
Placebo
Intervention Description
Matching placebo will be administered subcutaneously with accessorized prefilled syringe (APFS) every 4 weeks for the first 3 doses - Weeks 0, 4 and 8, and then every 8 weeks until the end of treatment.
Primary Outcome Measure Information:
Title
Annualized rate of moderate or severe COPD exacerbations
Description
Moderate or severe COPD exacerbation is defined by symptomatic worsening of COPD requiring: Use of systemic corticosteroids for at least 3 days; and/or Use of antibiotics; and/or An inpatient hospitalization or death due to COPD
Time Frame
Over first 56 weeks
Secondary Outcome Measure Information:
Title
Annualized rate of severe COPD exacerbations
Description
A severe COPD exacerbation is defined by symptomatic worsening of COPD requiring an inpatient hospitalization or results in death due to COPD
Time Frame
Minimum of 1 year and an average of 2 years
Title
Annualized rate of COPD exacerbations that are associated with an emergency room/emergency department visit or a hospitalization
Time Frame
Minimum of 1 year and an average of 2 years
Title
Time to first COPD exacerbation
Time Frame
During first 56 weeks
Title
Change from baseline in SGRQ total and domain scores
Description
St. George's Respiratory Questionnaire (SGRQ)
Time Frame
up to 56 weeks
Title
Change from baseline in E-RS:COPD total and domain scores
Description
Evaluating Respiratory Symptoms in COPD (E-RS:COPD)
Time Frame
up to 56 weeks
Title
Change from baseline in pre-dose/pre-bronchodilator FEV1
Description
FEV1 is the Forced expiratory volume in one second at study site
Time Frame
up to 56 weeks
Title
All cause and respiratory-related mortality rate
Time Frame
Minimum of 1 year and an average of 2 years
Title
Annual rate of hospitalizations due to COPD
Time Frame
Minimum of 1 year and an average of 2 years
Title
Serum benralizumab concentration as a measure of pharmacokinetics
Time Frame
up to 56 weeks
Title
Anti-drug antibodies (ADA) as a measure of immunogenicity
Time Frame
up to 56 weeks
Title
Change from baseline in CAT total score
Description
Chronic Obstructive Pulmonary Disease assessment tool (CAT)
Time Frame
up to 56 weeks
Title
Length of hospital stay
Time Frame
Minimum of 1 year and an average of 2 years
Title
ICU (Intensive Care Unit) days
Time Frame
Minimum of 1 year and an average of 2 years
Title
Annual rate of hospitalizations and emergency department visits combined
Time Frame
Minimum of 1 year and an average of 2 years
Title
Annual rate of unscheduled outpatient visits including unscheduled visits to study sites
Time Frame
Minimum of 1 year and an average of 2 years
Title
Annual rate of unscheduled healthcare encounters
Time Frame
Minimum of 1 year and and average of 2 years
Other Pre-specified Outcome Measures:
Title
Safety and tolerability of benralizumab in patients with moderate to very severe COPD
Description
AEs, vital signs, clinical laboratory, and ECG
Time Frame
Minimum of 1 year and average of 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Provision of informed consent Age 40 to 85 years Male and/or female. Current or former smoker with a tobacco history of ≥10 pack-years. History of moderate to very severe COPD with a post-bronchodilator FEV1/FVC<0.70 and FEV1 ≤65% of predicted normal value. Documented history of 2 or more COPD exacerbations that required treatment with systemic corticosteroids and/or hospitalization within 52 weeks prior to enrollment. Exacerbations treated with antibiotics alone are excluded unless accompanied by treatment with systemic corticosteroids and/or hospitalization. Hospitalization is defined as an inpatient admission ≥24 hours Previous exacerbations should be confirmed to have occurred while on stable triple therapy for COPD. At least one qualifying COPD exacerbation should occur while on stable uninterrupted triple therapy prior to enrolment. Documented use of triple (ICS/LABA/LAMA) background therapy for COPD for ≥3 months immediately prior to enrollment. Treatment with at least double inhaled therapy containing ICS (e.g. ICS/LABA or ICS/LAMA) for the remaining of 52 weeks prior to enrolment. Use of LABA/LAMA is allowed if ICS cannot be tolerated. ICS in a dose approved for COPD or equivalent to ≥250 mcg of fluticasone propionate daily. Total cumulative duration of not being on double or triple background therapy must not exceed 2 months. Stable therapy/doses for the last 3 months prior to randomization. Blood eosinophil count ≥300/μL at screening and documented historical eosinophil count of ≥150/μL within 52 weeks of enrollment (or repeated testing during run-in). CAT total score ≥15 at Visit 1. Negative pregnancy test for females of childbearing potential (WOCBP) at Visit 1. Women of childbearing potential (WOCBP) must agree to use a highly effective method of birth control from enrollment throughout the study and within 12 weeks after last dose of IP. Women not of childbearing potential are defined as women who are either permanently sterilized or postmenopausal (confirmed by FSH test for women <50 years). Exclusion Criteria: Clinically important pulmonary disease other than COPD Current diagnosis of asthma, prior history of asthma or asthma-COPD overlap according to GINA/GOLD. Childhood history of asthma is allowed and defined as asthma diagnosed and resolved before the age of 18. Radiological findings of a respiratory disease other than COPD contributing to respiratory symptoms. Solitary pulmonary nodules without appropriate follow up or findings of acute infection. Another pulmonary or systemic disease associated with elevated peripheral eosinophil counts. Any unstable disorder that could affect patient safety, study findings or the patient's ability to complete the study. Any clinically significant abnormal findings in physical examination, vital signs, ECG, laboratory tests could affect patient safety, study findings or the patient's ability to complete the study. Cor pulmonale and/or right ventricular failure. Long-term treatment with oxygen >4.0 L/min and/or oxyhemoglobin saturation <89% while breathing supplemental oxygen. Use of any non-invasive positive pressure ventilation device (NIPPV). Note: use of CPAP for Sleep Apnea Syndrome is allowed. Known immunodeficiency disorder, including positive HIV-1/2 testing. Active liver disease. Chronic stable hepatitis B and C (including positive HBsAg or hepatitis C antibody testing), or other stable chronic liver disease are acceptable. ALT or AST ≥3 times the upper limit of normal, confirmed by repeated testing during the run-in period. Helminth parasitic infection within 24 weeks prior to enrollment, not treated or failed to respond to standard of care therapy. Alcohol or drug abuse within the past year, which may compromise the study data. Malignancy, current or within the past 5 years, except for adequately treated non invasive basal cell and squamous cell carcinoma of the skin and cervical carcinoma-in-situ treated with apparent success more than 1 year prior to Visit 1. Suspected malignancy or undefined neoplasms. Evidence of active tuberculosis, as judged by investigator. Patients with a recent (within 2 years) first-time or newly positive PPD or Quantiferon test need to complete an appropriate course of treatment before enrollment. Evaluation will be according to the local standard of care. Participation, or planned participation, in intensive COPD rehabilitation program (maintenance phase of a rehabilitation is allowed). History of surgical or endoscopic lung volume reduction within the 6 months prior to enrollment. History of partial or total lung resection (single lobe or segmentectomy is acceptable). Scheduled major surgical procedure during the study. Minor elective procedures are allowed. History of anaphylaxis to any biologic therapy or vaccine. Receipt of blood products or immunoglobulins within 30 days prior to randomization. Receipt of marketed or investigational biologic product within 4 months or 5 half-lives prior to randomization, whichever is longer. Exception: Patients on stable therapy for 3 months before randomization who intend to stay on treatment throughout the study with marketed biologic products that are not likely to interfere with the safety assessment and/or efficacy of benralizumab, for example, for the treatment of osteoporosis, migraine, pain, diabetes, obesity, ocular, cardiovascular, or metabolic diseases, can participate in the study. Receipt of live attenuated vaccines 30 days prior to randomization. Chronic use of immunosuppressive medication or expected need for chronic use during the study. Chronic use of antibiotics if duration of treatment is <9 months prior to randomization. Chronic macrolide or other antibiotic therapy is allowed provided the patient has been on stable dose/regimen for ≥9 months prior to randomization and has had ≥2 COPD exacerbations while on stable therapy. Receipt of any investigational non-biologic product within 30 days or 5 half-lives prior to enrollment. Receipt of benralizumab within 12 months prior to enrollment. Known history of allergy or reaction to any component of the IP formulation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
AstraZeneca Clinical Study Information Center
Phone
1-877-240-9479
Email
information.center@astrazeneca.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerard Criner, MD
Organizational Affiliation
Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research Site
City
Montgomery
State/Province
Alabama
ZIP/Postal Code
36116
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Surprise
State/Province
Arizona
ZIP/Postal Code
85374
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85723
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States
Individual Site Status
Suspended
Facility Name
Research Site
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72209
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Newport Beach
State/Province
California
ZIP/Postal Code
92663
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Northridge
State/Province
California
ZIP/Postal Code
91324
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Palm Springs
State/Province
California
ZIP/Postal Code
92262
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Palm Springs
State/Province
California
ZIP/Postal Code
92262
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Individual Site Status
Suspended
Facility Name
Research Site
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Westminster
State/Province
California
ZIP/Postal Code
92683
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Stamford
State/Province
Connecticut
ZIP/Postal Code
06902
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Newark
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Brandon
State/Province
Florida
ZIP/Postal Code
33511
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Daytona Beach
State/Province
Florida
ZIP/Postal Code
32117
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Edgewater
State/Province
Florida
ZIP/Postal Code
32132
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32204
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32209
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34746
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Leesburg
State/Province
Florida
ZIP/Postal Code
34748
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32819
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Pensacola
State/Province
Florida
ZIP/Postal Code
32503
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33707
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33607
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32789
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Columbus
State/Province
Georgia
ZIP/Postal Code
31904
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30033
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Lawrenceville
State/Province
Georgia
ZIP/Postal Code
30046
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Rincon
State/Province
Georgia
ZIP/Postal Code
31326
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Woodstock
State/Province
Georgia
ZIP/Postal Code
30189
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
O'Fallon
State/Province
Illinois
ZIP/Postal Code
62269
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Peoria
State/Province
Illinois
ZIP/Postal Code
61636
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Michigan City
State/Province
Indiana
ZIP/Postal Code
46360
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Valparaiso
State/Province
Indiana
ZIP/Postal Code
46383
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Council Bluffs
State/Province
Iowa
ZIP/Postal Code
51503
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Georgetown
State/Province
Kentucky
ZIP/Postal Code
40324
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40502
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Columbia
State/Province
Maryland
ZIP/Postal Code
21044
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
North Dartmouth
State/Province
Massachusetts
ZIP/Postal Code
02747
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Farmington Hills
State/Province
Michigan
ZIP/Postal Code
48336
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68510
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68124
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Brick
State/Province
New Jersey
ZIP/Postal Code
08724
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Toms River
State/Province
New Jersey
ZIP/Postal Code
08755
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10455
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
New Windsor
State/Province
New York
ZIP/Postal Code
12553
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Potsdam
State/Province
New York
ZIP/Postal Code
13676
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Burlington
State/Province
North Carolina
ZIP/Postal Code
27215
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27517
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28287
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Elizabeth City
State/Province
North Carolina
ZIP/Postal Code
27909
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Gastonia
State/Province
North Carolina
ZIP/Postal Code
28054
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Huntersville
State/Province
North Carolina
ZIP/Postal Code
28078
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Mooresville
State/Province
North Carolina
ZIP/Postal Code
28117
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
New Bern
State/Province
North Carolina
ZIP/Postal Code
28562
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58104
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45220
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43215
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73106
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Happy Valley
State/Province
Oregon
ZIP/Postal Code
97086
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Doylestown
State/Province
Pennsylvania
ZIP/Postal Code
18901
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
DuBois
State/Province
Pennsylvania
ZIP/Postal Code
15801
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19140
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Smithfield
State/Province
Pennsylvania
ZIP/Postal Code
15478
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29407
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Mount Pleasant
State/Province
South Carolina
ZIP/Postal Code
29464
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29406
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Rock Hill
State/Province
South Carolina
ZIP/Postal Code
29732
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57702
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37404
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
37067
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hendersonville
State/Province
Tennessee
ZIP/Postal Code
37075
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Johnson City
State/Province
Tennessee
ZIP/Postal Code
37601
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79106
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79124
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Cypress
State/Province
Texas
ZIP/Postal Code
77429
Country
United States
Individual Site Status
Suspended
Facility Name
Research Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77079
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Kerrville
State/Province
Texas
ZIP/Postal Code
78028
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78258
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Spring
State/Province
Texas
ZIP/Postal Code
77380
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Tomball
State/Province
Texas
ZIP/Postal Code
77375
Country
United States
Individual Site Status
Terminated
Facility Name
Research Site
City
Weatherford
State/Province
Texas
ZIP/Postal Code
76086
Country
United States
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84102
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
White River Junction
State/Province
Vermont
ZIP/Postal Code
05009
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Abingdon
State/Province
Virginia
ZIP/Postal Code
24210
Country
United States
Individual Site Status
Completed
Facility Name
Research Site
City
Salem
State/Province
Virginia
ZIP/Postal Code
24153
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Williamsburg
State/Province
Virginia
ZIP/Postal Code
23188
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Research Site
City
Everett
State/Province
Washington
ZIP/Postal Code
98208
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Everett
State/Province
Washington
ZIP/Postal Code
98208
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99204
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26505
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Cudahy
State/Province
Wisconsin
ZIP/Postal Code
53110
Country
United States
Individual Site Status
Recruiting
Facility Name
Research Site
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53295
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
S2000PBJ
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Caba
ZIP/Postal Code
C1012AAR
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Ciudad Autónoma de Buenos Aire
ZIP/Postal Code
C1440BRR
Country
Argentina
Individual Site Status
Terminated
Facility Name
Research Site
City
Ciudad de Buenos Aires
ZIP/Postal Code
1425
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Córdoba
ZIP/Postal Code
X5003DCE
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Florencio Varela
ZIP/Postal Code
1888
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Florida
ZIP/Postal Code
B1602DQD
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Mar del Plata
ZIP/Postal Code
B7600GWV
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Mendoza
ZIP/Postal Code
M5500GIP
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
San Fernando
ZIP/Postal Code
B1646EBJ
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
San Miguel de Tucuman
ZIP/Postal Code
4000
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Research Site
City
Caringbah
ZIP/Postal Code
2229
Country
Australia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Melbourne
ZIP/Postal Code
3004
Country
Australia
Individual Site Status
Recruiting
Facility Name
Research Site
City
South Brisbane
ZIP/Postal Code
4101
Country
Australia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Southport
ZIP/Postal Code
4215
Country
Australia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Spearwood
ZIP/Postal Code
6163
Country
Australia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Bad Ischl
ZIP/Postal Code
4820
Country
Austria
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Bludenz
ZIP/Postal Code
6700
Country
Austria
Individual Site Status
Recruiting
Facility Name
Research Site
City
Feldbach
ZIP/Postal Code
A-8330
Country
Austria
Individual Site Status
Recruiting
Facility Name
Research Site
City
Grieskirchen
ZIP/Postal Code
4710
Country
Austria
Individual Site Status
Recruiting
Facility Name
Research Site
City
Linz
ZIP/Postal Code
4020
Country
Austria
Individual Site Status
Recruiting
Facility Name
Research Site
City
Thalheim
ZIP/Postal Code
4600
Country
Austria
Individual Site Status
Terminated
Facility Name
Research Site
City
Edegem
ZIP/Postal Code
2650
Country
Belgium
Individual Site Status
Recruiting
Facility Name
Research Site
City
Erpent
ZIP/Postal Code
5101
Country
Belgium
Individual Site Status
Recruiting
Facility Name
Research Site
City
Yvoir
ZIP/Postal Code
5530
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Blumenau
ZIP/Postal Code
89030-101
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Botucatu
ZIP/Postal Code
18.618-686
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Florianópolis
ZIP/Postal Code
88036-800
Country
Brazil
Individual Site Status
Terminated
Facility Name
Research Site
City
Maringa
ZIP/Postal Code
87015-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Porto Alegre
ZIP/Postal Code
9002-060
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Porto Alegre
ZIP/Postal Code
90020-090
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Porto Alegre
ZIP/Postal Code
90610-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Porto Alegre
ZIP/Postal Code
91350-200
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Santo Andre
ZIP/Postal Code
09080-110
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sao Bernardo do Campo
ZIP/Postal Code
09750-420
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sao Paulo
ZIP/Postal Code
05403-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sorocaba
ZIP/Postal Code
18040-425
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Research Site
City
Uberlandia
ZIP/Postal Code
38411-186
Country
Brazil
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Kozloduy
ZIP/Postal Code
3320
Country
Bulgaria
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Ruse
ZIP/Postal Code
7002
Country
Bulgaria
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3B 0M3
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5J 3S9
Country
Canada
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Kelowna
State/Province
British Columbia
ZIP/Postal Code
V1Y 3H5
Country
Canada
Individual Site Status
Withdrawn
Facility Name
Research Site
City
St. John's
State/Province
NF
ZIP/Postal Code
A1A 3R5
Country
Canada
Individual Site Status
Terminated
Facility Name
Research Site
City
Bridgewater
State/Province
Nova Scotia
ZIP/Postal Code
B4V 3N2
Country
Canada
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Lower Sackville
State/Province
Nova Scotia
ZIP/Postal Code
B4C 2S4
Country
Canada
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Ajax
State/Province
Ontario
ZIP/Postal Code
L1S 2J5
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Barrie
State/Province
Ontario
ZIP/Postal Code
L4M 6M2
Country
Canada
Individual Site Status
Terminated
Facility Name
Research Site
City
Sarnia
State/Province
Ontario
ZIP/Postal Code
N7T 4X3
Country
Canada
Individual Site Status
Terminated
Facility Name
Research Site
City
Stouffville
State/Province
Ontario
ZIP/Postal Code
L4A 1H2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T 3A9
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9V 4B4
Country
Canada
Individual Site Status
Terminated
Facility Name
Research Site
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H4A 3J1
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Saskatoon
State/Province
Saskatchewan
ZIP/Postal Code
S7N 0W8
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chicoutimi
ZIP/Postal Code
G7H 5H6
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Quebec
ZIP/Postal Code
G1V 4W2
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Quebec
ZIP/Postal Code
G1W 4R4
Country
Canada
Individual Site Status
Terminated
Facility Name
Research Site
City
Quebec
ZIP/Postal Code
G2J 0C4
Country
Canada
Individual Site Status
Recruiting
Facility Name
Research Site
City
Curico
ZIP/Postal Code
3341643
Country
Chile
Individual Site Status
Recruiting
Facility Name
Research Site
City
Quillota
ZIP/Postal Code
2260000
Country
Chile
Individual Site Status
Recruiting
Facility Name
Research Site
City
Santiago
ZIP/Postal Code
7500571
Country
Chile
Individual Site Status
Terminated
Facility Name
Research Site
City
Santiago
ZIP/Postal Code
7500692
Country
Chile
Individual Site Status
Recruiting
Facility Name
Research Site
City
Santiago
ZIP/Postal Code
7500698
Country
Chile
Individual Site Status
Terminated
Facility Name
Research Site
City
Santiago
ZIP/Postal Code
8380453
Country
Chile
Individual Site Status
Recruiting
Facility Name
Research Site
City
Talca
ZIP/Postal Code
3465584
Country
Chile
Individual Site Status
Recruiting
Facility Name
Research Site
City
Viña del Mar
ZIP/Postal Code
2520997
Country
Chile
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Baotou
ZIP/Postal Code
14010
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Beijing
ZIP/Postal Code
100034
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Beijing
ZIP/Postal Code
102218
Country
China
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
410005
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
410015
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
430033
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chengdu
ZIP/Postal Code
610041
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chengdu
ZIP/Postal Code
610072
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Chongqing
ZIP/Postal Code
402260
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Ganzhou
ZIP/Postal Code
341000
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guangzhou
ZIP/Postal Code
510180
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guangzhou
ZIP/Postal Code
510630
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guiyang
ZIP/Postal Code
550002
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Haikou
ZIP/Postal Code
570311
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hangzhou
ZIP/Postal Code
310006
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Hebei
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hefei
ZIP/Postal Code
230001
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hohhot
ZIP/Postal Code
010017
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hohhot
ZIP/Postal Code
10050
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kunming
ZIP/Postal Code
650032
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Linhai
ZIP/Postal Code
317000
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Nanchang
ZIP/Postal Code
330006
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Nanjing
ZIP/Postal Code
210011
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Nanjing
ZIP/Postal Code
210012
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200002
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200092
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200240
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200433
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shenyang
ZIP/Postal Code
100003
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Shenyang
ZIP/Postal Code
110015
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shenzhen
ZIP/Postal Code
518020
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shenzhen
ZIP/Postal Code
518039
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Shijiazhuang
ZIP/Postal Code
50051
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Suzhou
ZIP/Postal Code
215000
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Urumqi
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wenzhou
ZIP/Postal Code
325027
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wuhan
ZIP/Postal Code
430030
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wuhan
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Xi'an
ZIP/Postal Code
710061
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Yangzhou
ZIP/Postal Code
225000
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Yanji
ZIP/Postal Code
133000
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Yinchuan
ZIP/Postal Code
750001
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Yinchuan
ZIP/Postal Code
750004
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Yiyang
ZIP/Postal Code
413000
Country
China
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Zhanjiang
ZIP/Postal Code
524001
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Zhengzhou
ZIP/Postal Code
450003
Country
China
Individual Site Status
Recruiting
Facility Name
Research Site
City
Barranquilla
ZIP/Postal Code
80007
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Cali
ZIP/Postal Code
76001000
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Floridablanca
ZIP/Postal Code
681004
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Medellin
ZIP/Postal Code
050621
Country
Colombia
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Medellin
ZIP/Postal Code
5001000
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Pereira
ZIP/Postal Code
660003
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Rionegro
ZIP/Postal Code
54048
Country
Colombia
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Zipaquira
ZIP/Postal Code
200251
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Research Site
City
Brandys nad Labem
ZIP/Postal Code
250 01
Country
Czechia
Individual Site Status
Active, not recruiting
Facility Name
Research Site
City
Jindrichuv Hradec
ZIP/Postal Code
377 01
Country
Czechia
Individual Site Status
Completed
Facility Name
Research Site
City
Ostrava
ZIP/Postal Code
708 68
Country
Czechia
Individual Site Status
Completed
Facility Name
Research Site
City
Rokycany
ZIP/Postal Code
337 22
Country
Czechia
Individual Site Status
Active, not recruiting
Facility Name
Research Site
City
Teplice
ZIP/Postal Code
415 01
Country
Czechia
Individual Site Status
Completed
Facility Name
Research Site
City
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
København NV
ZIP/Postal Code
2400
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
Odense C
ZIP/Postal Code
5000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
Roskilde
ZIP/Postal Code
4000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
Vejle
ZIP/Postal Code
7100
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
Ålborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Research Site
City
Aachen
ZIP/Postal Code
52074
Country
Germany
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Bamberg
ZIP/Postal Code
96049
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Berlin
ZIP/Postal Code
10717
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Berlin
ZIP/Postal Code
12157
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Berlin
ZIP/Postal Code
13187
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Darmstadt
ZIP/Postal Code
64283
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hamburg
ZIP/Postal Code
20354
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hannover
ZIP/Postal Code
D-30173
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Koblenz
ZIP/Postal Code
56068
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Köln
ZIP/Postal Code
51069
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Leipzig
ZIP/Postal Code
04103
Country
Germany
Individual Site Status
Terminated
Facility Name
Research Site
City
Leipzig
ZIP/Postal Code
04207
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Leipzig
ZIP/Postal Code
04357
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Marburg
ZIP/Postal Code
35037
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Marburg
ZIP/Postal Code
35037
Country
Germany
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Neu-Isenburg
ZIP/Postal Code
63263
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Peine
ZIP/Postal Code
31224
Country
Germany
Individual Site Status
Recruiting
Facility Name
Research Site
City
Potsdam
ZIP/Postal Code
14467
Country
Germany
Individual Site Status
Completed
Facility Name
Research Site
City
Rheine
ZIP/Postal Code
48431
Country
Germany
Individual Site Status
Terminated
Facility Name
Research Site
City
Warendorf
ZIP/Postal Code
48231
Country
Germany
Individual Site Status
Terminated
Facility Name
Research Site
City
Athens
ZIP/Postal Code
10676
Country
Greece
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Athens
ZIP/Postal Code
11527
Country
Greece
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Athens
ZIP/Postal Code
11527
Country
Greece
Individual Site Status
Recruiting
Facility Name
Research Site
City
Athens
ZIP/Postal Code
12462
Country
Greece
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Exohi Thessaloniki
ZIP/Postal Code
57010
Country
Greece
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Heraklion
ZIP/Postal Code
71110
Country
Greece
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Ioannina
ZIP/Postal Code
45500
Country
Greece
Individual Site Status
Recruiting
Facility Name
Research Site
City
Thessaloniki
ZIP/Postal Code
56429
Country
Greece
Individual Site Status
Completed
Facility Name
Research Site
City
Thessaloniki
ZIP/Postal Code
57010
Country
Greece
Individual Site Status
Recruiting
Facility Name
Research Site
City
Balassagyarmat
ZIP/Postal Code
2660
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1033
Country
Hungary
Individual Site Status
Terminated
Facility Name
Research Site
City
Edelény
ZIP/Postal Code
3780
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Encs
ZIP/Postal Code
3860
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Gödöllő
ZIP/Postal Code
2100
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hajdúnánás
ZIP/Postal Code
4080
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Komárom
ZIP/Postal Code
2900
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Pécs
ZIP/Postal Code
7635
Country
Hungary
Individual Site Status
Terminated
Facility Name
Research Site
City
Siófok
ZIP/Postal Code
8600
Country
Hungary
Individual Site Status
Terminated
Facility Name
Research Site
City
Szeged
ZIP/Postal Code
6722
Country
Hungary
Individual Site Status
Terminated
Facility Name
Research Site
City
Százhalombatta
ZIP/Postal Code
2440
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Research Site
City
Törökbálint
ZIP/Postal Code
2045
Country
Hungary
Individual Site Status
Terminated
Facility Name
Research Site
City
Ahmedabad
ZIP/Postal Code
380006
Country
India
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Ansari Nagar
ZIP/Postal Code
110 029
Country
India
Individual Site Status
Suspended
Facility Name
Research Site
City
Calicut
ZIP/Postal Code
673 008
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Chennai
ZIP/Postal Code
600116
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Coimbatore
ZIP/Postal Code
641028
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Delhi
ZIP/Postal Code
110029
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Guntur
ZIP/Postal Code
522005
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Hyderabad
ZIP/Postal Code
500038
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Jaipur
ZIP/Postal Code
302039
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Pune
ZIP/Postal Code
411047
Country
India
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Thane
ZIP/Postal Code
401107
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Vijayawada
ZIP/Postal Code
520 008
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Catanzaro
ZIP/Postal Code
88100
Country
Italy
Individual Site Status
Suspended
Facility Name
Research Site
City
Cona
ZIP/Postal Code
44124
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Genova
ZIP/Postal Code
16132
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Milano
ZIP/Postal Code
20142
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Milano
ZIP/Postal Code
20157
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Napoli
ZIP/Postal Code
80131
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Reggio Emilia
ZIP/Postal Code
42123
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Roma
ZIP/Postal Code
00168
Country
Italy
Individual Site Status
Recruiting
Facility Name
Research Site
City
Rozzano
ZIP/Postal Code
20089
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Chuo-ku
ZIP/Postal Code
103-0022
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chuo-ku
ZIP/Postal Code
104-0031
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chuo-ku
ZIP/Postal Code
104-0031
Country
Japan
Individual Site Status
Terminated
Facility Name
Research Site
City
Fukuoka-shi
ZIP/Postal Code
814-0180
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Himeji-shi
ZIP/Postal Code
672-8064
Country
Japan
Individual Site Status
Terminated
Facility Name
Research Site
City
Hitachinaka-shi
ZIP/Postal Code
312-0057
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Joyo-shi
ZIP/Postal Code
610-0113
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kasuga-shi
ZIP/Postal Code
816-0813
Country
Japan
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Kawachinagano-shi
ZIP/Postal Code
586-8521
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kishiwada-shi
ZIP/Postal Code
596-8501
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kobe-shi
ZIP/Postal Code
650-0047
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Koto-ku
ZIP/Postal Code
136-0075
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kure-shi
ZIP/Postal Code
737-0023
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Matsusaka-shi
ZIP/Postal Code
515-8544
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Meguro-ku
ZIP/Postal Code
152-8902
Country
Japan
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Mizunami-shi
ZIP/Postal Code
509-6134
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Research Site
City
Nagaoka-shi
ZIP/Postal Code
940-2085
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Nagoya-shi
ZIP/Postal Code
457-8511
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Nishinomiya-shi
ZIP/Postal Code
663-8501
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Okayama-shi
ZIP/Postal Code
700-8558
Country
Japan
Individual Site Status
Terminated
Facility Name
Research Site
City
Osaka-shi
ZIP/Postal Code
531-0073
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sagamihara-shi
ZIP/Postal Code
252-0315
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sakai-shi
ZIP/Postal Code
591-8555
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Sakaide-shi
ZIP/Postal Code
762-8550
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Seto-shi
ZIP/Postal Code
489-8642
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Shinagawa-ku
ZIP/Postal Code
140-8522
Country
Japan
Individual Site Status
Terminated
Facility Name
Research Site
City
Shinagawa-ku
ZIP/Postal Code
142-8666
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toshima-ku
ZIP/Postal Code
170-0002
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toshima-ku
ZIP/Postal Code
170-0003
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toshima-ku
ZIP/Postal Code
171-0014
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Toyonaka-shi
ZIP/Postal Code
560-8552
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Ueda-shi
ZIP/Postal Code
386-8610
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Yanagawa-shi
ZIP/Postal Code
832-0059
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Yokohama-shi
ZIP/Postal Code
223-0059
Country
Japan
Individual Site Status
Recruiting
Facility Name
Research Site
City
Daegu
ZIP/Postal Code
42415
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Jeonju-si
ZIP/Postal Code
54907
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
03312
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
04401
Country
Korea, Republic of
Individual Site Status
Terminated
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
05030
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
06591
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wonju-si
ZIP/Postal Code
26426
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guadalajara
ZIP/Postal Code
44100
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guadalajara
ZIP/Postal Code
44130
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Guadalajara
ZIP/Postal Code
44200
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Mexico
ZIP/Postal Code
07760
Country
Mexico
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Monterrey
ZIP/Postal Code
64460
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Mérida
ZIP/Postal Code
97070
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Veracruz
ZIP/Postal Code
91910
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Research Site
City
Amersfoort
ZIP/Postal Code
3813 TZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Research Site
City
Breda
ZIP/Postal Code
4818 CK
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Research Site
City
Den Haag
ZIP/Postal Code
2512 VA
Country
Netherlands
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Leeuwarden
ZIP/Postal Code
8934 AD
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Research Site
City
Auckland
ZIP/Postal Code
0626
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Research Site
City
Auckland
ZIP/Postal Code
1051
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Research Site
City
Christchurch
ZIP/Postal Code
8024
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Research Site
City
Dunedin
ZIP/Postal Code
9016
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hamilton
ZIP/Postal Code
3204
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Research Site
City
Cavite City
ZIP/Postal Code
4114
Country
Philippines
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Iloilo City
ZIP/Postal Code
5000
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Research Site
City
Los Baños
ZIP/Postal Code
4030
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Research Site
City
Marilao
ZIP/Postal Code
3019
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Research Site
City
Quezon City
ZIP/Postal Code
1100
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Research Site
City
Białystok
ZIP/Postal Code
15-044
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Grodzisk Mazowiecki
ZIP/Postal Code
05-825
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Katowice
ZIP/Postal Code
40-648
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Krakow
ZIP/Postal Code
30-727
Country
Poland
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Ostrowiec Świętokrzyski
ZIP/Postal Code
27-400
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Poznań
ZIP/Postal Code
60-693
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Poznań
ZIP/Postal Code
61-578
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Proszowice
ZIP/Postal Code
32-100
Country
Poland
Individual Site Status
Terminated
Facility Name
Research Site
City
Rzeszów
ZIP/Postal Code
35-051
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Skierniewice
ZIP/Postal Code
96-100
Country
Poland
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Warszawa
ZIP/Postal Code
02-793
Country
Poland
Individual Site Status
Terminated
Facility Name
Research Site
City
Wieluń
ZIP/Postal Code
98-300
Country
Poland
Individual Site Status
Terminated
Facility Name
Research Site
City
Łódź
ZIP/Postal Code
90-153
Country
Poland
Individual Site Status
Recruiting
Facility Name
Research Site
City
Caguas
ZIP/Postal Code
00726
Country
Puerto Rico
Individual Site Status
Recruiting
Facility Name
Research Site
City
San Juan
ZIP/Postal Code
00918
Country
Puerto Rico
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Barcelona
ZIP/Postal Code
08017
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Hospitalet de Llobregat(Barcel
ZIP/Postal Code
08907
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Laredo
ZIP/Postal Code
39770
Country
Spain
Individual Site Status
Completed
Facility Name
Research Site
City
Madrid
ZIP/Postal Code
28007
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Madrid
ZIP/Postal Code
28850
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Malaga
ZIP/Postal Code
29010
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Santander
ZIP/Postal Code
39008
Country
Spain
Individual Site Status
Recruiting
Facility Name
Research Site
City
Göteborg
ZIP/Postal Code
413 45
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Research Site
City
Göteborg
ZIP/Postal Code
413 46
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Research Site
City
Helsingborg
ZIP/Postal Code
25220
Country
Sweden
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Lund
ZIP/Postal Code
222 22
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Research Site
City
Malmö
ZIP/Postal Code
205 02
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Research Site
City
Stockholm
ZIP/Postal Code
114 46
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Research Site
City
Adana
ZIP/Postal Code
01330
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
Ankara
ZIP/Postal Code
06
Country
Turkey
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Antalya
ZIP/Postal Code
07070
Country
Turkey
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Istanbul
ZIP/Postal Code
34098
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
İstanbul
ZIP/Postal Code
34844
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
Izmir
ZIP/Postal Code
35110
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
Kocaeli
ZIP/Postal Code
41380
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
Mersin
ZIP/Postal Code
33343
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Research Site
City
Barnsley
ZIP/Postal Code
S75 3DL
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Birmingham
ZIP/Postal Code
B9 5SS
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Blackpool
ZIP/Postal Code
FY2 0JH
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Bradford
ZIP/Postal Code
BD9 6RJ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Chertsey
ZIP/Postal Code
KT16 0PZ
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Research Site
City
Cottingham
ZIP/Postal Code
HU16 5JQ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Larbert
ZIP/Postal Code
FK5 4WR
Country
United Kingdom
Individual Site Status
Withdrawn
Facility Name
Research Site
City
Leicester
ZIP/Postal Code
LE3 9QP
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Manchester
ZIP/Postal Code
M13 9NQ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Oxford
ZIP/Postal Code
OX3 7LE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Perth
ZIP/Postal Code
PH1 1NX
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Southampton
ZIP/Postal Code
SO166YD
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Stockton-on-Tees
ZIP/Postal Code
TS17 6EW
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Wishaw
ZIP/Postal Code
ML2 0DP
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Research Site
City
Hanoi
ZIP/Postal Code
100000
Country
Vietnam
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Ho Chi Minh city
ZIP/Postal Code
700000
Country
Vietnam
Individual Site Status
Not yet recruiting
Facility Name
Research Site
City
Ho Chi Minh
ZIP/Postal Code
700000
Country
Vietnam
Individual Site Status
Not yet recruiting

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment.
IPD Sharing Time Frame
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles.
IPD Sharing Access Criteria
When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access.
IPD Sharing URL
https://astrazenecagroup-dt.pharmacm.com/DT/Home
Links:
URL
https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D3251C00014&amp;attachmentIdentifier=e179b7eb-c2d8-4b45-ad4d-14aef6dbee7a&amp;fileName=RESOLUTE_Poster.pdf&amp;versionIdentifier=
Description
This is a poster on the Resolute study.

Learn more about this trial

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

We'll reach out to this number within 24 hrs